G9796 High-Intensity Statin Therapy HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS G9796: High-Intensity Statin Therapy

HCPCS Level II code G9796 denotes that a patient is currently receiving high-intensity statin therapy. This designation captures documentation of active, intensive lipid-lowering treatment commonly used for secondary prevention of atherosclerotic cardiovascular disease and for certain high-risk primary prevention populations. Nationwide, standardized capture of high-intensity statin use supports quality measurement, care coordination, and payer program design related to cardiovascular risk reduction.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical intent of the code, common sites of service, and how the code fits into quality reporting and medication management workflows. The publication outlines benchmarks and reporting considerations, summarizes relevant policy updates affecting coding and documentation, and situates G9796 within outpatient chronic disease management processes. Practical takeaways emphasize documentation clarity, expected use cases, and how the code interoperates with broader quality and reimbursement frameworks.

Data not available in the input for associated taxonomies, specific ICD-10 pairings, or service-line charge details.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9796HCPCS Level IIhigh-intensity statinmedication managementoutpatient carequality measurementlipid therapycardiovascular preventionclinical documentation

Billing Code Overview

HCPCS Level II code G9796 indicates that the patient is currently on a high intensity statin therapy. The service represented is documentation and reporting of current high-intensity statin use, reflecting ongoing pharmacologic management for patients who require aggressive lipid-lowering therapy.

Service type: Medication management / pharmacologic therapy documentation
Typical site of service: Ambulatory clinic or outpatient physician office where medication reconciliation and chronic disease management occur

Clinical & Coding Specifications

Clinical Context

A 62-year-old patient with established atherosclerotic cardiovascular disease (history of myocardial infarction and peripheral arterial disease) attends a follow-up outpatient cardiology visit. The patient is already prescribed a high-intensity statin (for example, atorvastatin 80 mg daily or rosuvastatin 40 mg daily) and reports good adherence but has persistent elevated LDL-C despite therapy. The clinical workflow includes medication reconciliation, review of lipid panel results, assessment for statin intolerance or adverse effects, documentation that the patient is currently on high-intensity statin therapy, and planning for further lipid-lowering management (such as adding ezetimibe or PCSK9 inhibitor) or referral to lipidology. Typical site of service is an outpatient ambulatory clinic (cardiology, primary care, or preventive cardiology clinic). Ancillary services during the visit may include phlebotomy for fasting lipid panel and orders for prior authorization if additional lipid-lowering agents are considered.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	When substantially greater work is performed beyond usual for the visit or service documentation supports increased complexity related to statin management and counseling.
`23`

HCPCS G9946: Back Pain VAS/Numeric Score Not Measured at 1-Year Postop

HCPCS-G8663-SHOULDER-IMPAIRMENT-RESIDUAL-SCORE-CALCULATION

HCPCS G8663: Shoulder Impairment Residual Score

HCPCS-G8825-PATIENT-NOT-DISCHARGED-TO-HOME-POST-OP-DAY-7

HCPCS G8825: Patient Not Discharged to Home by Post-Op Day 7

HCPCS-G2107-FRAIL-OLDER-ADULTS-ADVANCED-ILLNESS

HCPCS G2107: Frailty with Advanced Illness in Older Adults

HCPCS-G9919-SCREENING-POSITIVE-WITH-RECOMMENDATIONS

HCPCS G9919: Screening Positive With Provision of Recommendations

HCPCS-G0407-FOLLOW-UP-INPATIENT-CONSULTATION-INTERMEDIATE-TELEHEALTH

HCPCS G0407: Follow-Up Inpatient Consultation, Intermediate

HCPCS-G9751-PATIENT-DEATH-24-MONTH-MEASUREMENT-PERIOD

HCPCS G9751: Patient Died During 24-Month Measurement Period

HCPCS-G9965-MISSED-WELL-CHILD-VISIT-PRIMARY-CARE

HCPCS G9965: Missed Well-Child Visit with Primary Care Provider

HCPCS-G9582-DOOR-TO-PUNCTURE-OVER-90-MINUTES-NO-REASON

HCPCS G9582: Door-to-Puncture Time >90 Minutes, No Reason Given

HCPCS-G0663-TEAM-REMOTE-E-M-NEW-PATIENT-45-MINS

HCPCS G0663: Team Remote E/M for New Patient, 45 Minutes

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207RC0000X`	Cardiology	Cardiologists commonly manage high-intensity statin therapy for secondary prevention.
`208D00000X`	Internal Medicine	Primary care physicians manage initiation and follow-up of statin therapy for primary and secondary prevention.
`207RH0002X`	Interventional Cardiology	May be involved for patients with recent procedures and secondary prevention management.
`363L00000X`	Nurse Practitioner	Advanced practice providers frequently manage medication therapy and follow-up in clinic.
`363A00000X`	Physician Assistant	PAs commonly provide follow-up visits and medication management for lipid therapy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E78.00`	Pure hypercholesterolemia, unspecified	Common indication for high-intensity statin therapy when LDL-C is elevated.
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Secondary prevention indication for high-intensity statin therapy.
`I21.9`	Acute myocardial infarction, unspecified	Recent MI prompts high-intensity statin therapy for secondary prevention.
`E78.5`	Hyperlipidemia, unspecified	General diagnosis driving lipid-lowering therapy including high-intensity statins.
`I73.9`	Peripheral vascular disease, unspecified	Atherosclerotic disease prompting aggressive lipid management with high-intensity statin therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for follow-up visits where current high-intensity statin therapy status is documented and medication management is addressed.
`80061`	Lipid panel; total cholesterol, HDL, and triglycerides, with calculation of LDL cholesterol	Often ordered during the visit to assess response to high-intensity statin therapy and guide further management.
`99495`	Transitional care management services with moderate medical decision complexity, face-to-face within 14 days of discharge	May be used if review of high-intensity statin therapy occurs shortly after hospital discharge as part of transitional care.
`36415`	Collection of venous blood by venipuncture	Performed to obtain lipid panels during the office visit or laboratory visit.
`96372`	Therapeutic, prophylactic, or diagnostic injection (subcutaneous or intramuscular)	Used if an injectable lipid-lowering agent (e.g., PCSK9 inhibitor) is administered in clinic following documentation of high-intensity statin therapy and treatment escalation.

OpenPayer